drugset / Trial / NCT04963257

Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

NCT04963257

RandomizedParallel-groupOpen-labelTreatment

Summary

To verify that sertraline combined with fluvoxamine is superior to sertraline combined with aripiprazole

Timeline

Start
2020-01-01
Primary completion
2023-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 5 mg
Comparator Aripiprazole Other / unclassified 20 mg
Subject Fluvoxamine Unknown 200 mg
Subject Fluvoxamine Unknown 300 mg
Background Sertraline Small molecule 200 mg